Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,035 | -25,021 | -69,045 | -49,198 | -18,037 |
| Depreciation Amortization | 632 | 317 | 972 | 679 | 458 |
| Other Working Capital | -2,353 | -1,692 | -9,646 | -10,203 | -10,295 |
| Other Operating Activity | -3,005 | 15,812 | 30,296 | 19,405 | -1,756 |
| Operating Cash Flow | $-20,761 | $-10,584 | $-47,423 | $-39,317 | $-29,630 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,616 | -250 | -8,134 | -5,744 | -2,232 |
| Investing Cash Flow | $-1,616 | $-250 | $-8,134 | $-5,744 | $-2,232 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 34,889 | 34,889 | 54,026 | 54,026 | N/A |
| Debt Repayment | N/A | N/A | N/A | N/A | 29,226 |
| Common Stock Issued | 130 | 42 | 5 | 5 | N/A |
| Other Financing Activity | 0 | 0 | -43 | 0 | 0 |
| Financing Cash Flow | $35,019 | $34,931 | $53,988 | $54,031 | $29,226 |
| Beginning Cash Position | 19,243 | 19,243 | 20,812 | 20,812 | 20,812 |
| End Cash Position | 31,885 | 43,340 | 19,243 | 29,782 | 18,176 |
| Net Cash Flow | $12,642 | $24,097 | $-1,569 | $8,970 | $-2,636 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,761 | -10,584 | -47,423 | -39,317 | -29,630 |
| Capital Expenditure | -1,616 | -250 | -8,144 | -5,744 | -2,232 |
| Free Cash Flow | -22,377 | -10,834 | -55,567 | -45,061 | -31,862 |